Dexcom (DXCM.O), opens new tab said on Monday its over-the-counter continuous glucose monitor, Stelo, is now available for use in the United States at a price of up to $99.
Stelo was cleared by the U.S. health regulator in March for use by adults aged 18 and older who do not use insulin, making it the the first continuous glucose monitor available for over-the-counter sales.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,